USRE40624EExpiredUtility
Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)
Est. expiryNov 4, 2023(expired)· nominal 20-yr term from priority
C12Q 1/6883C07K 14/4747C12N 9/1205C12Q 2600/158C12Q 2600/136C12Q 2600/156A61P 5/50A61P 3/10A61K 38/00C12N 9/12
68
PatentIndex Score
0
Cited by
24
References
5
Claims
Abstract
The invention provides apoptosis signaling kinase related kinase (ASKRK) nucleic acid and polypeptide sequences and methods of using such sequences to identify modulators of ASKRK. Such modulators can be used for the treatment of diabetes or for delaying the onset of diabetes. The invention also provides methods of diagnosing diabetes or pre-diabetes and methods of making a prognosis based on the detection of ASKRK nucleic acids and proteins.
Claims
exact text as granted — not AI-modified1. An isolated nucleic acid encoding a polypeptide comprising SEQ ID NO:2.
2. The isolated nucleic acid of claim 1 , wherein the nucleic acid comprises SEQ ID NO:1.
3. An expression vector comprising the nucleic acid of claim 1 .
4. A host cell in vitro comprising the expression vector of claim 3 .
5. The host cell of claim 4 , wherein the host cell is a pancreatic beta cell.Join the waitlist — get patent alerts
Track USRE40624E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.